UTI Medium Term Fund - Direct Plan - Growth Option
UTI Medium Term Fund - Direct Plan - Growth Option

UTI Medium Term Fund - Direct Plan - Growth Option

Debt
Direct
Moderately High risk
Medium Duration

NAV: ₹ 15.58 as on 20-10-2021

Fund Overview

Expense ratio
Expense ratio
0.97%
Benchmark
Benchmark
CRISIL Short Term Bond Fund TR INR
AUM
AUM
₹67 Cr
Inception Date
Inception Date
31 March, 2015
Min Lumpsum/SIP
Min Lumpsum/SIP
₹500/₹1500
Exit Load
Exit Load
1%
Lock In
Lock In
No Lock-in
TurnOver
TurnOver
0%

Fund Distribution

  • Debt & Cash 100%
Credit rating breakup
AAA
60.82%
AA
31.09%
A
8.09%
Sector Allocation
Corporate
50.1%
Government
41.3%
Cash Equivalent
8.7%

Top Holdings

  • All
  • Debt & Cash
Total Holdings18
Debt Holdings18
7.59% Govt Stock 2029
7.59% Govt Stock 2029
12.1%
Net Current Assets
Net Current Assets
8.3%
7.26% Govt Stock 2029
7.26% Govt Stock 2029
7.9%
Reliance Industries Limited
Reliance Industries Limited
7.7%
The Indian Hotels Company Limited
The Indian Hotels Company Limited
7.6%
Telesonic Networks Limited
Telesonic Networks Limited
7.5%
Amba River Coke Limited
Amba River Coke Limited
7.5%
Dilip Buildcon Limited
Dilip Buildcon Limited
7.4%

Fund Highlights

Fund Manager
Fund Manager

Fund Manager

Amandeep Chopra,Ritesh Nambiar
About the fund

About the fund

This fund has delivered an average annual returns of 7.02% since inception which is more than its category average return of 3.46%
Fund Allocations

Fund Allocations

This fund has an allocation of 0% in Equity, 91.3% in Debt and 8.7% in Cash related instruments
AUM size ₹67 Cr

AUM size ₹67 Cr

This fund has AUM of ₹67 Cr which is less than its category average of ₹ 1590 Cr
Expense Ratio 0.97%

Expense Ratio 0.97%

This fund has an expense ratio of 0.97% which is more than its category average expense ratio of 0.82%

AMC details

Fund House
UTI Asset Management Co Ltd
Email
service@uti.co.in
Phone
+912266786666
Address
PMS Division, UTI - Tower, “Gn” Block, Bandra Kurla Complex, Mumbai- 400051
We are a SEBI registered investement advisor